INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

76,369 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VT
Van Hauwermeiren TimothyDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
Page 755 of 1910
← PrevNext →
traded Jun 25, 2026
+4d
SEC Form 4

Evidence

9
CE
Crowley ElizabethSR. VP & CPDO
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
WJ
Wollin Robert JGENERAL COUNSEL AND SECRETARY
MGTXMeiraGTx Holdings plc
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
14 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
RS
Renda Frankie S.Director, PRESIDENT AND CEO, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
55.4K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
24 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
LE
Luebke Taylor EdwardSVP and CFO
LZBLA-Z-BOY INC
Tax withholding
F$5,201
127 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

9
TT
Tanguler TolgaDirector
LXEOLexeo Therapeutics, Inc.
Grant or award
A—
35.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
CS
Campbell ShannonDirector
BDTXBlack Diamond Therapeutics, Inc.
Grant or award
A—
40.0K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

9
RV
Renda Rudolph V.Director, CO-COO AND EVP, 10% Owner
SLNDSouthland Holdings, Inc.
Option exercise
M—
15.7K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
TD
Torres DeniceDirector
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
26.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
ZK
Zeldin Robert KCHIEF MEDICAL OFFICER
MGTXMeiraGTx Holdings plc
Grant or award
A—
100.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
JR
Jain RitaDirector
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
26.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
KA
Kandarian Steven ADirector
JXNJackson Financial Inc.
Grant or award
A—
951 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
8 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
FA
Forbes AlexandriaDirector, PRESIDENT & CEO
MGTXMeiraGTx Holdings plc
Grant or award
A—
980.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
AA
Anderson Craig A.SVP and Controller
JXNJackson Financial Inc.
Grant or award
A—
14 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
SR
Sundy Robert IIPresident, Retail
LZBLA-Z-BOY INC
Tax withholding
F$12K
296 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

9
RC
Raub ChristopherEVP JFI; CEO PPM America
JXNJackson Financial Inc.
Grant or award
A—
22 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
KG
Kirkland Derek GDirector
JXNJackson Financial Inc.
Grant or award
A—
125 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
BP
Binioris Savvas Steve PanagiotisEVP and Chief Risk Officer
JXNJackson Financial Inc.
Grant or award
A—
41 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
PL
Prieskorn Laura LoueneDirector, CEO and President
JXNJackson Financial Inc.
Grant or award
A—
152 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

9
MB
Martin Samuel BatesSVP AND CFO
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
93.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

8
CC
Cushman Elizabeth C.EVP, GC AND SECRETARY
ABTABBOTT LABORATORIES
Tax withholding
F$53K
560 sh
Jun 27, 2026Jun 29, 2026
traded Jun 27, 2026
+2dSEC Form 4

Evidence

8
GE
Gilliam Joseph EPRESIDENT & COO
GKOSGLAUKOS Corp
Tax withholding
F$151K
1,056 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

8
AH
Anderson David HugoDirector
NWNNorthwest Natural Holding Co
Open-market sale · 10b5-1 plan
SELL$76K
1,500 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$26K
79 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$36K
110 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$49K
150 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

7
SF
Schmidt James FDirector, CFO, Treasurer, Secretary
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$17K
50 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

6
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,200 sh
Jun 29, 2026Jun 29, 2026
traded Jun 29, 2026
+0dSEC Form 4

Evidence

5
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Tax withholding
F$27K
659 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

5
ML
McCurry Jennifer LynnChief Accounting Officer
LZBLA-Z-BOY INC
Tax withholding
F$10K
253 sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC Form 4

Evidence

5
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Tax withholding
F$15K
365 sh
Jun 28, 2026Jun 29, 2026
traded Jun 28, 2026
+1dSEC Form 4

Evidence

5
JA
Jimenez Freddy A.SVP & GENERAL COUNSEL
CLDXCelldex Therapeutics, Inc.
Grant or award
A—
93.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
GK
Goodrich KatherineDirector
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
3,837 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Tax withholding
F$69K
483 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
GK
Goodrich KatherineDirector
TARSTarsus Pharmaceuticals, Inc.
Grant or award
A—
2,417 sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence

5
NS
Naylor StuartCHIEF SCI OFCR, OPHTHALMOLOGY
MGTXMeiraGTx Holdings plc
Grant or award
A—
70.0K sh
Jun 25, 2026Jun 29, 2026
traded Jun 25, 2026
+4dSEC Form 4

Evidence